BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 18971993)

  • 1. Pharmaceutical futures: a fiendish puzzle.
    Abbott A
    Nature; 2008 Oct; 455(7217):1164-7. PubMed ID: 18971993
    [No Abstract]   [Full Text] [Related]  

  • 2. The impact of systems approaches on biological problems in drug discovery.
    Hood L; Perlmutter RM
    Nat Biotechnol; 2004 Oct; 22(10):1215-7. PubMed ID: 15470453
    [No Abstract]   [Full Text] [Related]  

  • 3. Synthetic biology offers alternative pathways to natural products.
    Herrera S
    Nat Biotechnol; 2005 Mar; 23(3):270-1. PubMed ID: 15765068
    [No Abstract]   [Full Text] [Related]  

  • 4. Marc Kirschner. Interview by Asher Mullard.
    Kirschner M
    Nat Rev Drug Discov; 2011 Dec; 10(12):894. PubMed ID: 22129982
    [No Abstract]   [Full Text] [Related]  

  • 5. Will genomics revolutionise pharmaceutical R&D?
    Noble D
    Trends Biotechnol; 2003 Aug; 21(8):333-7. PubMed ID: 12902169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards quantitative biology: integration of biological information to elucidate disease pathways and to guide drug discovery.
    Fischer HP
    Biotechnol Annu Rev; 2005; 11():1-68. PubMed ID: 16216773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug discovery: playing dirty.
    Frantz S
    Nature; 2005 Oct; 437(7061):942-3. PubMed ID: 16222266
    [No Abstract]   [Full Text] [Related]  

  • 8. Next-generation model-based drug discovery and development: quantitative and systems pharmacology.
    Allerheiligen SR
    Clin Pharmacol Ther; 2010 Jul; 88(1):135-7. PubMed ID: 20531467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond genomics.
    Dollery CT
    Clin Pharmacol Ther; 2007 Oct; 82(4):366-70. PubMed ID: 17851575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery strategies in a BioPharmaceutical startup: maximising your chances of success using computational filters.
    Jennings A; Tennant M
    Curr Pharm Des; 2005; 11(3):335-44. PubMed ID: 15723629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can complexity be commercialized?
    Mack GS
    Nat Biotechnol; 2004 Oct; 22(10):1223-9. PubMed ID: 15470456
    [No Abstract]   [Full Text] [Related]  

  • 12. Editorial to the second issue dedicated to Lewis Sheiner.
    Rowland M
    J Pharmacokinet Pharmacodyn; 2006 Jun; 33(3):223-5. PubMed ID: 16683187
    [No Abstract]   [Full Text] [Related]  

  • 13. Editorial: Accelerating systems biology.
    Mazza T
    Brief Bioinform; 2010 May; 11(3):267-9. PubMed ID: 20478854
    [No Abstract]   [Full Text] [Related]  

  • 14. P systems applications to systems biology.
    Gheorghe M; Krasnogor N; Camara M
    Biosystems; 2008 Mar; 91(3):435-7. PubMed ID: 17728056
    [No Abstract]   [Full Text] [Related]  

  • 15. In pursuit of systems.
    Nature; 2005 May; 435(7038):1. PubMed ID: 15874978
    [No Abstract]   [Full Text] [Related]  

  • 16. Systems biology: an evolving approach in drug discovery and development.
    Ho RL; Lieu CA
    Drugs R D; 2008; 9(4):203-16. PubMed ID: 18588352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent developments in the monitoring, modeling and control of biological production systems.
    Mandenius CF
    Bioprocess Biosyst Eng; 2004 Dec; 26(6):347-51. PubMed ID: 15597197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell biology gets plugged in.
    Gershon D
    Nature; 2002 Jun; 417(6892):6. PubMed ID: 12087361
    [No Abstract]   [Full Text] [Related]  

  • 19. Integrating systems approaches into pharmaceutical sciences.
    Westerhoff HV; Mosekilde E; Noe CR; Clemensen AM
    Eur J Pharm Sci; 2008 Sep; 35(1-2):1-4. PubMed ID: 18602464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The end of the beginning for genomic medicine.
    Bailey D; Zanders E; Dean P
    Nat Biotechnol; 2001 Mar; 19(3):207-9. PubMed ID: 11231543
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.